AVEO Oncology downgraded by Stifel with a new price target
$AVEO
Biotechnology: Pharmaceutical Preparations
Health Care
Stifel downgraded AVEO Oncology from Buy to Hold and set a new price target of $15.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/8/2022 | $15.00 | Buy → Hold | Stifel |
| 7/12/2021 | $27.00 → $19.00 | Buy | HC Wainwright & Co. |